### Filing Overview **Filing Date**: February 28, 2022 **Type of Filing**: [[Filing Definitions#Prospectus Supplement|Prospectus Supplement]] **Linked Document**:: --- ### Notes - **Update to Prospectus**: - This filing updates the **Prospectus dated October 7, 2021**, part of Rocket Lab’s Registration Statements **333-259797** and **333-257440**. - **Details**: - **Securities Offered**: - 16,266,666 shares of common stock underlying warrants. - 5,600,000 warrants offered by selling securityholders. - 417,404,393 shares of common stock offered by selling securityholders. - **Nasdaq Listing**: The common stock is listed under the symbol **RKLB**, with the last reported sale price at **$9.45 per share** as of February 25, 2022. - **Plan of Distribution Update**: - Selling securityholders that are entities may distribute securities in-kind to their members, partners, or stockholders, enabling non-affiliated recipients to receive freely tradable securities. - Additional prospectus supplements may be filed for affiliated distributions. - **Additional Notes**: - Rocket Lab continues to operate as an **“emerging growth company”**, availing itself of reduced disclosure and regulatory requirements. - Investors are advised to review the "Risk Factors" section starting on page 9 of the original Prospectus. --- ![[cf861b50-3b2a-4d8f-b12b-1c836a65f372.pdf]] #SECFiling #424B3